81 FR 3471 - Certain Windshield Wiper Devices and Components Thereof; Commission Decision To Review In Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions
INTERNATIONAL TRADE COMMISSION Federal Register Volume 81, Issue 13 (January 21, 2016)
Federal Register Volume 81, Issue 13 (January 21, 2016)
| Page Range | 3471-3473 | |
| FR Document | 2016-01089 |
[Federal Register Volume 81, Number 13 (Thursday, January 21, 2016)] [Notices] [Pages 3471-3473] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-01089] ======================================================================= ----------------------------------------------------------------------- INTERNATIONAL TRADE COMMISSION [Investigation No. 337-TA-934] Certain Windshield Wiper Devices and Components Thereof; Commission Decision To Review In Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions AGENCY: U.S. International Trade Commission. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Notice is hereby given that the U.S. International Trade Commission has determined to review in part the presiding administrative law judge's (``ALJ'') final initial determination (``final ID'') issued on October 27, 2015 finding a violation of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (``section 337'') in the above-captioned investigation. FOR FURTHER INFORMATION CONTACT: Megan M. Valentine, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 708-2301. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205-2000. General information concerning the Commission may also be obtained by accessing its Internet server at http://www.usitc.gov. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission's TDD terminal on (202) 205-1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on October 27, 2014, based on a Complaint filed by Nobel Biocare Services AG of Switzerland and Nobel Biocare USA, LLC of Yorba Linda, California (collectively, ``Nobel''), as supplemented. 79 FR 63940-41 (Oct. 27, 2014). The Complaint alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (``section 337''), in the sale for importation, importation, and sale within the United States after importation of certain dental implants by reason of infringement of certain claims of U.S. Patent Nos. 8,714,977 (``the '977 patent'') and 8,764,443 (``the '443 patent''). The Complaint further alleges the existence of a domestic industry. The Commission's Notice of Investigation named as respondents Neodent USA, Inc., of Andover, Massachusetts and JJGC Ind[uacute]stria e Com[eacute]rcio de Materiais Dent[aacute]rios S/A of Curitiba, Brazil (collectively, ``Respondents''). The Commission previously terminated the investigation in part as to certain claims of the '443 patent. Notice (Apr. 29, 2015); Order No. 22 (Apr. 8, 2015). The Commission also amended the Notice of Investigation to reflect the corporate name change of Neodent USA, Inc. to lnstradent USA, Inc. Notice (May 6, 2015); Order No. 24 (Apr. 9, 2015). The use of the term ``Respondents'' herein refers to the current named respondents. On October 27, 2015, the ALJ issued his final ID, finding a violation of section 337 with respect to asserted claims 15, 18, 19, 30, and 32 of the '443 patent, and finding no violation with respect to asserted claim 17 of the '443 patent and all of the asserted claims of the '977 patent. In particular, the final ID finds that the accused products infringe claims 1-5 and 19 of the '977 patent and claims 15, 18, 19, 30, and 32 of the '443 patent, but do not infringe claim 17 of the '443 patent. The final ID also found that Respondents have shown that the asserted claims of the '977 patent are invalid for anticipation under 35 U.S.C. 102, but have not shown that the asserted claims of the '443 are invalid. In addition, the final ID found that Respondents failed to show that the asserted claims of the '977 and '443 patents are unenforceable due to inequitable conduct. The final ID further found that Nobel has satisfied the domestic industry requirement with respect to both the '977 and '443 patents. On November 10, 2015, the ALJ issued his recommended determination (``RD'') on remedy and bonding. The RD recommended that the appropriate remedy is a limited exclusion order barring entry of Respondents' infringing dental implants. The RD did not recommend issuance of a cease and desist order against any respondent. The RD recommended the imposition of a bond of $120 per imported unit during the period of Presidential review. On November 9, 2015, Nobel filed a petition for review of the final ID's finding of no violation with respect to claims 1-5 of the '977 patent. In particular, Nobel requested review of the final ID's finding that the March 2003 Product Catalog of Alpha Bio Tec, Ltd. (``the 2003 Alpha Bio Tec Catalog'') constitutes prior art under 35 U.S.C. 102(b), arguing that the catalog was not sufficiently publicly accessible prior to the critical date. Nobel also requested, if the Commission determines not to review the ID's prior art finding, that the Commission review the final ID's construction of the limitation ``the coronal region having a frustoconical shape'' recited in claim 1 of the '977 patent and, accordingly, review the final ID's finding that the accused products do not infringe claims 1-5 of the '977 patent under Nobel's proposed construction of that limitation. Nobel further argued that, should the Commission agree partially with Nobel concerning the proper construction of the limitation ``the coronal region having a frustoconical shape,'' the 2003 Alpha-Bio Tec Catalog does not anticipate the asserted claims of the '977 patent. No party petitioned for review of the final ID's finding that there is a violation of section 337 with respect to the '443 patent. On November 17, 2015, Respondents and the Commission investigative attorney (``IA'') each filed responses opposing Nobel's petition for review. On December 10, 2015, Respondents submited a post-RD statement on the public interest pursuant to Commission [[Page 3472]] Rule 210.50(a)(4). On December 14, 2015, Nobel submited a post-RD statement on the public interest pursuant to Commission Rule 210.50(a)(4). No responses were filed by the public in response to the post-RD Commission Notice issued on November 12, 2015. See Notice of Request for Statements on the Public Interest, 80 FR 76574-75 (Dec. 9, 2015), see also Correction of Notice, 80 FR 77376-77 (Dec. 14, 2015). Having examined the record of this investigation, including the final ID, the petitions for review, and the responses thereto, the Commission has determined to review the final ID in part. Specifically, the Commission has determined to review the final ID's construction of the limitation ``coronal region having a frustoconical shape'' recited in claim 1 of the '977 patent with regard to whether or not the term ``frustoconical shape'' is an adjective that modifies the claimed ``coronal region'' or whether the term is an independent structure that may comprise only a portion of the claimed ``coronal region.'' In accordance with its claim construction review, the Commission has further determined to review the final ID's infringement findings with respect to claims 1-5 of the '977 patent, as well as the final ID's finding that the technical prong of the domestic industry requirement is satisfied with respect to claims 1-5 of the '977 patent. The Commission has also determined to review the final ID's finding that the 2003 Alpha Bio Tec Catalog is a printed publication under 35 U.S.C. 102. The Commission has further determined to review the final ID's finding that the 2003 Alpha Bio Tec Catalog anticipates claims 1-5 of the '977 patent. The Commission has determined not to review the remaining issues decided in the final ID. The parties are requested to brief their positions on the issues under review with reference to the applicable law and the evidentiary record. In connection with its review, the Commission is particularly interested in responses to the following questions: 1. With respect to the proper construction of the limitation ``coronal region having a frustoconical shape'' recited in claim 1 of the '977 patent, please address the meaning of the term ``frustoconical shape'' in the context of claim 1, and, in particular, whether the term is an adjective that merely modifies the claimed ``coronal region'' or whether the term may refer to an independent structure comprised within the claimed ``coronal region.'' In addition, please address the significance of the clause ``wherein a diameter of an apical end of the coronal region is larger than a diameter of a coronal end of the coronal region'' recited in claim 1 to the appropriate construction of the limitation ``coronal region having a frustoconical shape.'' Please discuss all governing precedent with respect to this issue. 2. With respect to whether the 2003 Alpha Bio Tec Catalog is prior art to the '977 patent, please address the significance of the evidence presented in exhibit JX-0278C, and the significance of the inclusion of the catalog in an information disclosure statement to the U.S. Patent and Trademark Office (see exhibit CX-0560). In addition, please address any evidence regarding the publication date of the 2003 Alpha Bio Tec Catalog, as well as any record evidence concerning whether and when the 2003 Alpha Bio Tec Catalog was ``publically accessible'' prior to the critical date under governing precedent. 3. Please address whether the 2003 Alpha Bio Tec Catalog anticipates the asserted claims of the '977 patent under a construction of the limitation ``coronal region having a frustoconical shape'' recited in claim 1 that requires the entire coronal region to be frustoconical but does not require any additional functional limitation. 4. With respect to whether the 2003 Alpha Bio Tec Catalog anticipates claim 2 of the '977 patent, please address the significance of the testimony of Nobel's expert, Mr. Hurson, that one of ordinary skill in the art would understand that any portion of an implant intended to mate with another component, e.g. an abutment, would never be acid-etched. In addition, please address whether or not the 2003 Alpha Bio Tec Catalog clearly and convincingly discloses that the bevel of the illustrated 5.0 mm SPI implant is acid etched. 5. Please address whether, under a construction of the limitation ``coronal region having a frustoconical shape'' recited in claim 1 of the '977 patent that requires the entire coronal region to be frustoconical but does not require any additional functional limitation, the technical prong of the domestic industry requirement is satisfied with respect to claim 1 of the '977 patent. The parties have been invited to brief only these discrete issues, as enumerated above, with reference to the applicable law and evidentiary record. The parties are not to brief other issues on review, which are adequately presented in the parties' existing filings. In connection with the final disposition of this investigation, the Commission may (1) issue an order that could result in the exclusion of the subject articles from entry into the United States, and/or (2) issue one or more cease and desist orders that could result in the respondent(s) being required to cease and desist from engaging in unfair acts in the importation and sale of such articles. Accordingly, the Commission is interested in receiving written submissions that address the form of remedy, if any, that should be ordered. If a party seeks exclusion of an article from entry into the United States for purposes other than entry for consumption, the party should so indicate and provide information establishing that activities involving other types of entry either are adversely affecting it or likely to do so. For background, see Certain Devices for Connecting Computers via Telephone Lines, Inv. No. 337-TA-360, USITC Pub. No. 2843 (December 1994) (Commission Opinion). If the Commission contemplates some form of remedy, it must consider the effects of that remedy upon the public interest. The factors the Commission will consider include the effect that an exclusion order and/or cease and desist orders would have on (1) the public health and welfare, (2) competitive conditions in the U.S. economy, (3) U.S. production of articles that are like or directly competitive with those that are subject to investigation, and (4) U.S. consumers. The Commission is therefore interested in receiving written submissions that address the aforementioned public interest factors in the context of this investigation. If the Commission orders some form of remedy, the U.S. Trade Representative, as delegated by the President, has 60 days to approve or disapprove the Commission's action. See Presidential Memorandum of July 21, 2005, 70 FR 43251 (July 26, 2005). During this period, the subject articles would be entitled to enter the United States under bond, in an amount determined by the Commission and prescribed by the Secretary of the Treasury. The Commission is therefore interested in receiving submissions concerning the amount of the bond that should be imposed if a remedy is ordered. Written Submissions: The parties to the investigation, including the Office of Unfair Import Investigations, are requested to file written submissions on the issues identified in this notice. Parties to the investigation, including the Office of Unfair Import Investigations, interested government agencies, and any other interested parties are encouraged to file written submissions on the issues of remedy, the public interest, and bonding. Such submissions should address the recommended determination by the ALJ on remedy and bonding. Complainant and the Office of Unfair Import Investigations are also requested to submit proposed remedial orders for the Commission's consideration. Complainant is further requested to state the dates that the patents expire, the HTSUS numbers under which the [[Page 3473]] accused products are imported, and any known importers of the accused products. The written submissions and proposed remedial orders must be filed no later than close of business on January 21, 2016. Initial submissions are limited to 50 pages, not including any attachments or exhibits related to discussion of the public interest. Reply submissions must be filed no later than the close of business on January 28, 2016. Reply submissions are limited to 25 pages, not including any attachments or exhibits related to discussion of the public interest. No further submissions on these issues will be permitted unless otherwise ordered by the Commission. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to Sec. 210.4(f) of the Commission's Rules of Practice and Procedure (19 CFR 210.4(f)). Submissions should refer to the investigation number (``Inv. No. 337-TA-934'') in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, http://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_filing.pdf). Persons with questions regarding filing should contact the Secretary (202-205-2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. A redacted non-confidential version of the document must also be filed simultaneously with any confidential filing. All non-confidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. On October 21, 2015, Nobel filed a motion to amend the Administrative Protective Order (``APO'') issued in this investigation to add specific provisions permitting the use of discovery from this investigation in two co-pending proceedings in the U.S. Patent and Trademark Office captioned as Instradent USA, Inc. v. Nobel Biocare Services AG, IPR2015-01784, and Instradent USA, Inc. v. Nobel Biocare Services AG, IPR2015-01786. On November 2, 2015, Respondents and the IA filed oppositions to Nobel's motion. On November 12, 2015, Nobel filed a motion for leave to file a reply in support of its motion to amend the APO. On November 23, 2015, Respondents filed an opposition to Nobel's motion for leave to file a reply. The Commission has determined to deny both Nobel's motion to amend the APO and motion for leave to file a reply in support of its motion. The authority for the Commission's determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: January 14, 2016. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2016-01089 Filed 1-20-16; 8:45 am] BILLING CODE 7020-02-P
![Federal Register / Vol. 81, No. 13 / Thursday, January 21, 2016 / Notices 3471
Federal oil and gas properties located documents filed in connection with this claim 17 of the ’443 patent. The final ID
in all other States where ONRR does not investigation are or will be available for also found that Respondents have
share a portion of Federal royalties with inspection during official business shown that the asserted claims of the
the State are eligible for relief if they hours (8:45 a.m. to 5:15 p.m.) in the ’977 patent are invalid for anticipation
qualify as marginal under the Office of the Secretary, U.S. under 35 U.S.C. 102, but have not
regulations (See section 117(c) of RSFA; International Trade Commission, 500 E shown that the asserted claims of the
30 U.S.C. 1726(c)). For information on Street SW., Washington, DC 20436, ’443 are invalid. In addition, the final ID
how to obtain relief, please refer to 30 telephone (202) 205–2000. General found that Respondents failed to show
CFR 1204.205 or to the published rule, information concerning the Commission that the asserted claims of the ’977 and
which you may view at http:// may also be obtained by accessing its ’443 patents are unenforceable due to
www.onrr.gov/Laws_R_D/FRNotices/ Internet server at http://www.usitc.gov. inequitable conduct. The final ID further
PDFDocs/55076.pdf. The public record for this investigation found that Nobel has satisfied the
Unless the information that ONRR may be viewed on the Commission’s domestic industry requirement with
received is proprietary data, all electronic docket (EDIS) at http:// respect to both the ’977 and ’443
correspondence, records, or information edis.usitc.gov. Hearing-impaired patents.
that we receive in response to this persons are advised that information on On November 10, 2015, the ALJ
notice may be subject to disclosure this matter can be obtained by issued his recommended determination
under the Freedom of Information Act contacting the Commission’s TDD (‘‘RD’’) on remedy and bonding. The RD
(FOIA) (5 U.S.C. 552 et seq.). If terminal on (202) 205–1810. recommended that the appropriate
applicable, please highlight the remedy is a limited exclusion order
SUPPLEMENTARY INFORMATION: The
proprietary portions, including any barring entry of Respondents’ infringing
Commission instituted this investigation
supporting documentation, or mark the dental implants. The RD did not
on October 27, 2014, based on a
page(s) that contain proprietary data. recommend issuance of a cease and
Complaint filed by Nobel Biocare
We protect the proprietary information desist order against any respondent. The
Services AG of Switzerland and Nobel
under the Trade Secrets Act (18 U.S.C. RD recommended the imposition of a
Biocare USA, LLC of Yorba Linda,
1905); FOIA, Exemption 4 (5 U.S.C. bond of $120 per imported unit during
California (collectively, ‘‘Nobel’’), as
552(b)(4)); and Department regulations the period of Presidential review.
supplemented. 79 FR 63940–41 (Oct. 27, On November 9, 2015, Nobel filed a
(43 CFR part 2). 2014). The Complaint alleges violations petition for review of the final ID’s
Dated: January 6, 2016. of section 337 of the Tariff Act of 1930, finding of no violation with respect to
Gregory J. Gould, as amended, 19 U.S.C. 1337 (‘‘section claims 1–5 of the ’977 patent. In
Director, Office of Natural Resources 337’’), in the sale for importation, particular, Nobel requested review of
Revenue. importation, and sale within the United the final ID’s finding that the March
[FR Doc. 2016–01079 Filed 1–20–16; 8:45 am] States after importation of certain dental 2003 Product Catalog of Alpha Bio Tec,
BILLING CODE 4335–30–P implants by reason of infringement of Ltd. (‘‘the 2003 Alpha Bio Tec Catalog’’)
certain claims of U.S. Patent Nos. constitutes prior art under 35 U.S.C.
8,714,977 (‘‘the ’977 patent’’) and 102(b), arguing that the catalog was not
INTERNATIONAL TRADE 8,764,443 (‘‘the ’443 patent’’). The sufficiently publicly accessible prior to
COMMISSION Complaint further alleges the existence the critical date. Nobel also requested, if
of a domestic industry. The the Commission determines not to
[Investigation No. 337–TA–934] Commission’s Notice of Investigation review the ID’s prior art finding, that the
Certain Windshield Wiper Devices and named as respondents Neodent USA, Commission review the final ID’s
Components Thereof; Commission Inc., of Andover, Massachusetts and construction of the limitation ‘‘the
Decision To Review In Part a Final JJGC Indústria e Comércio de Materiais coronal region having a frustoconical
Initial Determination Finding a Dentários S/A of Curitiba, Brazil shape’’ recited in claim 1 of the ’977
Violation of Section 337; Request for (collectively, ‘‘Respondents’’). The patent and, accordingly, review the final
Written Submissions Commission previously terminated the ID’s finding that the accused products
investigation in part as to certain claims do not infringe claims 1–5 of the ’977
AGENCY: U.S. International Trade of the ’443 patent. Notice (Apr. 29, patent under Nobel’s proposed
Commission. 2015); Order No. 22 (Apr. 8, 2015). The construction of that limitation. Nobel
ACTION: Notice. Commission also amended the Notice of further argued that, should the
Investigation to reflect the corporate Commission agree partially with Nobel
SUMMARY: Notice is hereby given that name change of Neodent USA, Inc. to
the U.S. International Trade concerning the proper construction of
lnstradent USA, Inc. Notice (May 6, the limitation ‘‘the coronal region
Commission has determined to review 2015); Order No. 24 (Apr. 9, 2015). The
in part the presiding administrative law having a frustoconical shape,’’ the 2003
use of the term ‘‘Respondents’’ herein Alpha-Bio Tec Catalog does not
judge’s (‘‘ALJ’’) final initial refers to the current named respondents.
determination (‘‘final ID’’) issued on anticipate the asserted claims of the ’977
On October 27, 2015, the ALJ issued patent.
October 27, 2015 finding a violation of his final ID, finding a violation of No party petitioned for review of the
section 337 of the Tariff Act of 1930, as section 337 with respect to asserted final ID’s finding that there is a violation
amended, 19 U.S.C. 1337 (‘‘section claims 15, 18, 19, 30, and 32 of the ’443 of section 337 with respect to the ’443
asabaliauskas on DSK9F6TC42PROD with NOTICES
337’’) in the above-captioned patent, and finding no violation with patent.
investigation. respect to asserted claim 17 of the ’443 On November 17, 2015, Respondents
FOR FURTHER INFORMATION CONTACT: patent and all of the asserted claims of and the Commission investigative
Megan M. Valentine, Office of the the ’977 patent. In particular, the final attorney (‘‘IA’’) each filed responses
General Counsel, U.S. International ID finds that the accused products opposing Nobel’s petition for review.
Trade Commission, 500 E Street SW., infringe claims 1–5 and 19 of the ’977 On December 10, 2015, Respondents
Washington, DC 20436, telephone (202) patent and claims 15, 18, 19, 30, and 32 submited a post-RD statement on the
708–2301. Copies of non-confidential of the ’443 patent, but do not infringe public interest pursuant to Commission
VerDate Sep<11>2014 18:26 Jan 20, 2016 Jkt 238001 PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 E:\FR\FM\21JAN1.SGM 21JAN1](https://thefederalregister.org/doc/81_FR_3484/page/1.svg)
![Federal Register / Vol. 81, No. 13 / Thursday, January 21, 2016 / Notices 3473
accused products are imported, and any motion for leave to file a reply in limited exclusion order and cease and
known importers of the accused support of its motion to amend the APO. desist orders.
products. The written submissions and On November 23, 2015, Respondents ADDRESSES: The complaint, except for
proposed remedial orders must be filed filed an opposition to Nobel’s motion any confidential information contained
no later than close of business on for leave to file a reply. therein, is available for inspection
January 21, 2016. Initial submissions are The Commission has determined to during official business hours (8:45 a.m.
limited to 50 pages, not including any deny both Nobel’s motion to amend the to 5:15 p.m.) in the Office of the
attachments or exhibits related to APO and motion for leave to file a reply Secretary, U.S. International Trade
discussion of the public interest. Reply in support of its motion. Commission, 500 E Street SW., Room
submissions must be filed no later than The authority for the Commission’s 112, Washington, DC 20436, telephone
the close of business on January 28, determination is contained in section (202) 205–2000. Hearing impaired
2016. Reply submissions are limited to 337 of the Tariff Act of 1930, as individuals are advised that information
25 pages, not including any attachments amended (19 U.S.C. 1337), and in Part on this matter can be obtained by
or exhibits related to discussion of the 210 of the Commission’s Rules of contacting the Commission’s TDD
public interest. No further submissions Practice and Procedure (19 CFR part terminal on (202) 205–1810. Persons
on these issues will be permitted unless 210). with mobility impairments who will
otherwise ordered by the Commission. need special assistance in gaining access
By order of the Commission.
Persons filing written submissions to the Commission should contact the
must file the original document Issued: January 14, 2016.
Office of the Secretary at (202) 205–
electronically on or before the deadlines Lisa R. Barton,
2000. General information concerning
stated above and submit 8 true paper Secretary to the Commission. the Commission may also be obtained
copies to the Office of the Secretary by [FR Doc. 2016–01089 Filed 1–20–16; 8:45 am] by accessing its Internet server at
noon the next day pursuant to § 210.4(f) BILLING CODE 7020–02–P http://www.usitc.gov. The public record
of the Commission’s Rules of Practice for this investigation may be viewed on
and Procedure (19 CFR 210.4(f)). the Commission’s electronic docket
Submissions should refer to the INTERNATIONAL TRADE (EDIS) at http://edis.usitc.gov.
investigation number (‘‘Inv. No. 337– COMMISSION FOR FURTHER INFORMATION CONTACT: The
TA–934’’) in a prominent place on the Office of Docket Services, U.S.
cover page and/or the first page. (See [Investigation No. 337–TA–983] International Trade Commission,
Handbook for Electronic Filing telephone (202) 205–1802.
Procedures, http://www.usitc.gov/ Certain Laser-Driven Light Sources,
secretary/fed_reg_notices/rules/ Subsystems Containing Laser-Driven Authority: The authority for institution of
this investigation is contained in section 337
handbook_on_electronic_filing.pdf). Light Sources, and Products of the Tariff Act of 1930, as amended, and
Persons with questions regarding filing Containing Same; Institution of in section 210.10 of the Commission’s Rules
should contact the Secretary (202–205– Investigation of Practice and Procedure, 19 CFR 210.10
2000). (2015).
Any person desiring to submit a AGENCY: U.S. International Trade
document to the Commission in Commission. Scope of Investigation: Having
confidence must request confidential ACTION: Notice. considered the complaint, the U.S.
treatment. All such requests should be International Trade Commission, on
directed to the Secretary to the SUMMARY: Notice is hereby given that a January 14, 2016, ordered that—
Commission and must include a full complaint was filed with the U.S. (1) Pursuant to subsection (b) of
statement of the reasons why the International Trade Commission on section 337 of the Tariff Act of 1930, as
Commission should grant such December 15, 2015, under section 337 of amended, an investigation be instituted
treatment. See 19 CFR 201.6. Documents the Tariff Act of 1930, as amended, 19 to determine whether there is a
for which confidential treatment by the U.S.C. 1337, on behalf of Energetiq violation of subsection (a)(1)(B) of
Commission is properly sought will be Technology, Inc. of Woburn, section 337 in the importation into the
treated accordingly. A redacted non- Massachusetts. A supplement to the United States, the sale for importation,
confidential version of the document complaint was filed on December 23, or the sale within the United States after
must also be filed simultaneously with 2015. The complaint, as supplemented, importation of certain laser-driven light
any confidential filing. All non- alleges violations of section 337 based sources, subsystems containing laser-
confidential written submissions will be upon the importation into the United driven light sources, and products
available for public inspection at the States, the sale for importation, and the containing same by reason of
Office of the Secretary and on EDIS. sale within the United States after infringement of one or more of claims
On October 21, 2015, Nobel filed a importation of certain laser-driven light 1–3, 6, 7, 10, 11, 13, 26, and 29 of the
motion to amend the Administrative sources, subsystems containing laser- ’841 patent; claims 1–6 and 15–18 of the
Protective Order (‘‘APO’’) issued in this driven light sources, and products ’000 patent; and claims 1, 6, 8, 13, 15,
investigation to add specific provisions containing same by reason of 20, 21, and 25 of the ’786 patent, and
permitting the use of discovery from infringement of certain claims of U.S. whether an industry in the United
this investigation in two co-pending Patent No. 8,969,841 (‘‘the ’841 patent’’); States exists as required by subsection
proceedings in the U.S. Patent and U.S. Patent No. 9,048,000 (‘‘the ’000 (a)(2) of section 337;
asabaliauskas on DSK9F6TC42PROD with NOTICES
Trademark Office captioned as patent’’); and U.S. Patent No. 9,185,786 (2) For the purpose of the
Instradent USA, Inc. v. Nobel Biocare (‘‘the ’786 patent’’). The complaint investigation so instituted, the following
Services AG, IPR2015–01784, and further alleges that an industry in the are hereby named as parties upon which
Instradent USA, Inc. v. Nobel Biocare United States exists as required by this notice of investigation shall be
Services AG, IPR2015–01786. On subsection (a)(2) of section 337. served:
November 2, 2015, Respondents and the The complainant requests that the (a) The complainant is: Energetiq
IA filed oppositions to Nobel’s motion. Commission institute an investigation Technology, Inc., 7 Constitution Way,
On November 12, 2015, Nobel filed a and, after the investigation, issue a Woburn, MA 01801.
VerDate Sep<11>2014 18:26 Jan 20, 2016 Jkt 238001 PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 E:\FR\FM\21JAN1.SGM 21JAN1](https://thefederalregister.org/doc/81_FR_3484/page/3.svg)
Document Created: 2018-02-02 12:34:11
Document Modified: 2018-02-02 12:34:11
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Megan M. Valentine, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 708-2301. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205-2000. General information concerning the Commission may also be obtained by accessing its Internet server at http:// www.usitc.gov. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission's TDD terminal on (202) 205-1810. | |
| FR Citation | 81 FR 3471 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR